AC Immune SA financial data

Symbol
ACIU on Nasdaq
Location
1015 Lausanne, Switzerland
Fiscal year end
31 December
Latest financial report
6-K - Q2 2024 - 06 Aug 2024

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense CHF17,138,000 CHF 25%
General And Administrative Expense CHF4,551,000 CHF 24%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets CHF237,535,000 CHF 52%
Liabilities CHF114,110,000 CHF 575%